Ian Woo
Ian Woo was appointed to the Board of Directors in October 2025. Currently, Mr. Woo is President, Chief Financial Officer and Executive Director of Everest Medicines Limited (HKEX: 1952), and also serves as an operating partner of CBC Group. Prior to that, Mr. Woo held the role of managing director of CBC Group and was a managing director in the global healthcare group of Lazard Frères & Co. LLC, working in the New York and Hong Kong offices. Mr. Woo served as an independent director and chairman of the Audit Committee of Prenetics Global Limited (Nasdaq: PRE) from May 2022 to May 2024. Mr. Woo earned a Bachelor of Science in Biology from Tufts University, a Master of Arts in Cellular, Molecular and Biomedical Studies from the Columbia University Graduate School of Arts and Sciences and a Master of Business Administration from the Columbia University Graduate School of Business.